Patents by Inventor Sabrina Green

Sabrina Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240335489
    Abstract: Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more of ES17, ES19, HP3, HP3.1, and HP3.2. Certain aspects of the disclosure are directed to compositions comprising (a) bacteriophage ES17 or bacteriophage ES19, (b) bacteriophage HP3, and (c) bacteriophage HP3.1. Also disclosed are compositions comprising bacteriophage HP 3.2. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic E. coli infection.
    Type: Application
    Filed: June 24, 2024
    Publication date: October 10, 2024
    Applicants: Baylor College of Medicine, United States Government as Represented by the Department of Veterans Affairs
    Inventors: Anthony Maresso, Robert Ramig, Sabrina Green, Austen Terwilliger, Keiko Salazar, Justin R. Clark, Barbara Trautner
  • Patent number: 12036255
    Abstract: Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more of ES17, ES19, HP3, HP3.1, and HP3.2. Certain aspects of the disclosure are directed to compositions comprising (a) bacteriophage ES17 or bacteriophage ES19, (b) bacteriophage HP3, and (c) bacteriophage HP3.1. Also disclosed are compositions comprising bacteriophage HP 3.2. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic E. coli infection.
    Type: Grant
    Filed: January 9, 2023
    Date of Patent: July 16, 2024
    Assignees: Baylor College of Medicine, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Anthony Maresso, Robert Ramig, Sabrina Green, Austen Terwilliger, Keiko Salazar, Justin R. Clark, Barbara Trautner
  • Publication number: 20240180980
    Abstract: Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more of ES17, ES19, HP3, HP3.1, and HP3.2. Certain aspects of the disclosure are directed to compositions comprising (a) bacteriophage ES17 or bacteriophage ES19, (b) bacteriophage HP3, and (c) bacteriophage HP3.1. Also disclosed are compositions comprising bacteriophage HP 3.2. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic E. coli infection.
    Type: Application
    Filed: January 9, 2023
    Publication date: June 6, 2024
    Inventors: Anthony Maresso, Robert Ramig, Austen Terwilliger, Sabrina Green, Keiko Salazar, Justin R. Clark, Barbara Trautner
  • Publication number: 20230241138
    Abstract: Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more of ES17, ES19, HP3, HP3.1, and HP3.2. Certain aspects of the disclosure are directed to compositions comprising (a) bacteriophage ES17 or bacteriophage ES19, (b) bacteriophage HP3, and (c) bacteriophage HP3.1. Also disclosed are compositions comprising bacteriophage HP 3.2. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic E. coli infection.
    Type: Application
    Filed: November 7, 2022
    Publication date: August 3, 2023
    Inventors: Anthony Maresso, Sabrina Green, Austen Terwilliger, Robert Ramig
  • Publication number: 20220340882
    Abstract: One aspect of the invention provides a method of generating bacteriophages adapted to infect a target bacterial strain. The method comprises: providing host bacteria that are susceptible to phage as input to a host chemostat containing phage; providing target bacteria that are related to the host bacteria, but not susceptible to phage as input to a target chemostat containing phage; filtering outflows from the host chemostat and the target chemostat to isolate phage from the populations of the host bacteria, the target bacteria, and macromolecules; combining the outflows; and introducing the combined outflow into each of the host chemostat and the target chemostat.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 27, 2022
    Applicant: Baylor College of Medicine
    Inventors: Justin Clark, Sabrina Green, Keiko Salazar, Austen Terwilliger, Anthony Maresso